Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil · Delayed Price · Currency is BRL 14.66
+0.05 (0.34%)
Oct 7, 2026, 5:05 PM GMT-3
BVMF:PNVL3 Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,190 | 1,790 | 1,314 | 1,989 | 1,507 | 1,980 | |
Market Cap Growth | 54.77% | 36.16% | -33.91% | 31.94% | -23.88% | -39.62% |
Enterprise Value | 3,298 | 2,802 | 2,257 | 2,798 | 2,242 | 2,469 |
Last Close Price | 14.61 | 11.54 | 8.31 | 12.20 | 9.09 | 11.71 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.07 | 14.36 | 12.46 | 21.41 | 17.46 | 24.93 |
Forward PE | 10.88 | 9.44 | 8.14 | 12.15 | 12.42 | 12.54 |
PS Ratio | 0.37 | 0.33 | 0.27 | 0.45 | 0.38 | 0.61 |
PB Ratio | 1.66 | 1.40 | 1.06 | 1.70 | 1.36 | 1.89 |
P/TBV Ratio | 1.81 | 1.53 | 1.16 | 1.82 | 1.46 | 2.01 |
P/FCF Ratio | 7.21 | 5.10 | 12.92 | 10.92 | 26.83 | 93.69 |
P/OCF Ratio | 5.18 | 3.78 | 5.86 | 6.70 | 7.34 | 15.09 |
PEG Ratio | 0.27 | 0.62 | 0.54 | 0.97 | 0.96 | 0.84 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.56 | 0.51 | 0.46 | 0.63 | 0.56 | 0.77 |
EV/EBITDA Ratio | 8.01 | 8.69 | 5.54 | 7.73 | 6.95 | 9.48 |
EV/EBIT Ratio | 11.74 | 10.91 | 11.44 | 17.29 | 16.27 | 24.02 |
EV/FCF Ratio | 10.87 | 7.99 | 22.19 | 15.36 | 39.91 | 116.83 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.07 | 1.18 | 1.00 | 0.87 | 0.79 | 0.66 |
Debt / EBITDA Ratio | 3.41 | 3.25 | 3.03 | 2.82 | 2.70 | 2.65 |
Debt / FCF Ratio | 4.64 | 4.29 | 12.15 | 5.61 | 15.51 | 32.69 |
Net Debt / Equity Ratio | 0.84 | 0.84 | 0.83 | 0.66 | 0.64 | 0.46 |
Net Debt / EBITDA Ratio | 4.17 | 3.34 | 2.51 | 2.15 | 2.22 | 1.85 |
Net Debt / FCF Ratio | 3.66 | 3.07 | 10.05 | 4.27 | 12.71 | 22.77 |
Asset Turnover | 1.68 | 1.53 | 1.53 | 1.54 | 1.56 | 1.41 |
Inventory Turnover | 3.45 | 3.18 | 3.10 | 3.25 | 3.36 | 3.40 |
Quick Ratio | 0.78 | 0.86 | 0.71 | 0.74 | 0.66 | 0.81 |
Current Ratio | 1.75 | 1.74 | 1.70 | 1.62 | 1.55 | 1.71 |
Return on Equity (ROE) | 10.79% | 9.90% | 8.76% | 8.14% | 8.02% | 7.72% |
Return on Assets (ROA) | 4.98% | 4.45% | 3.82% | 3.48% | 3.37% | 2.81% |
Return on Invested Capital (ROIC) | 9.96% | 9.53% | 8.79% | 8.58% | 8.23% | 7.12% |
Return on Capital Employed (ROCE) | 11.40% | 10.20% | 9.00% | 8.30% | 8.00% | 6.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.31% | 6.96% | 8.03% | 4.67% | 5.73% | 4.01% |
FCF Yield | 13.87% | 19.61% | 7.74% | 9.16% | 3.73% | 1.07% |
Dividend Yield | 1.72% | - | - | 2.06% | - | 1.49% |
Payout Ratio | 52.41% | 21.23% | 31.43% | 30.91% | 28.67% | 25.74% |
Buyback Yield / Dilution | -0.39% | 0.08% | -0.42% | -0.38% | 0.30% | 1.27% |
Total Shareholder Return | 1.31% | 0.08% | -0.42% | 1.68% | 0.30% | 2.76% |